Drug Discovery Postdoctoral Fellowship supports postdoctoral researchers’ early-stage drug discovery training to advance therapeutically relevant science with clear potential for translation to humans.
Funder: PhRMA Foundation
Due Dates (Anticipated): March 2027 (Full application) | October 2027 (Letter of Intent)
Funding Amounts: $60,000 per year in stipend support for 12, 18, or 24 months
Summary: Supports postdoctoral training in novel, early-stage drug discovery research with clear potential for translation to humans.
Key Information: Only one applicant per lab per cycle may apply to Drug Discovery; labs must choose a predoctoral or postdoctoral applicant.
The PhRMA Foundation’s Drug Discovery Postdoctoral Fellowship supports multidisciplinary, collaborative research training at accredited U.S. universities. It aims to extend researchers’ credentials while advancing innovative, early-stage discovery science toward effective, safe, and differentiated treatments for patients. All proposals must state a therapeutically relevant hypothesis and demonstrate clear potential for human translation.
Supported research includes target identification and validation, disease-mechanism mapping through single-cell and spatial multi-omics, hit and lead identification, molecular modeling, protein biochemistry, and structural biology. The program also supports cellular and molecular studies of therapeutic pathways, cell-based and animal studies of drug candidates’ pharmacological profiles, and advanced biomedical imaging. AI and computational approaches are eligible when they directly advance a therapeutic hypothesis.